Cases – Page 43 – ClaimsFiler

Recent Security Class Actions

On September 7, 2022, Sema4 Holdings Corp. was sued for violations of the federal securities laws in the United States District Court for the District of Connecticut on behalf of investors who purchased or otherwise acquired the Company’s securities between March 14, 2022 and August 15, 2022.

On September 2, 2022, Kohl's Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Wisconsin on behalf of investors who purchased or otherwise acquired the Company’s securities between October 20, 2020 and May 19, 2022.

On August 31, 2022, Abbott Laboratories was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased or otherwise acquired the Company’s shares between February 19, 2021 to June 8, 2022.

On August 31, 2022, TuSimple Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired: (a) the Company’s common stock pursuant to the April 2021 initial public offering (“IPO”) and/or (b) the Company’s securities between April 15, 2021 and August 1, 2022.

On August 31, 2022, Latch, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities between May 13, 2021 and August 25, 2022.

On August 30, 2022, Azure Power Global Limited was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities between June 15, 2021 and August 26, 2022.

On August 26, 2022, Stitch Fix, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s shares between December 8, 2020, and March 8, 2022.

On August 26, 2022, Coupang, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s shares in or traceable to the Company’s March 2021 initial public offering (“IPO”).

On August 26, 2022, Humanigen, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired the Company’s securities between May 28, 2021 and July 12, 2022.

On August 23, 2022, Bed Bath & Beyond Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Columbia on behalf of investors who purchased or otherwise acquired the Company’s shares between March 25, 2022 and August 18, 2022.

On August 19, 2022, Lottery.com was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities between November 15, 2021 and July 29, 2022.

On August 17, 2022, Ampio Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased the Company’s shares between December 29, 2020 and August 3, 2022.

On August 16, 2022, Co-Diagnostics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s publicly traded securities between May 12, 2022 and August 11, 2022.

On August 16, 2022, Uber Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s shares between May 31, 2019 and July 8, 2022.

On August 10, 2022, LifeStance Health Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s shares pursuant and/or traceable to the Company’s June 2021 initial public offering (the “IPO”).

On August 5, 2022, Kiromic BioPharma was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired: (a) Kiromic common stock pursuant to the July 2021 public offering and/or (b) Kiromic common stock between June 25, 2021 and August 13, 2021.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK